By analyzing The Cancer Genome Atlas (TCGA) data, we revealed that highly expressed CASC15 was positively related to poorer overall survival outcome (Fig. 1A), implying that CASC15 has a powerful prognostic value for GC patients and a potential oncogenic role in GC. This evidence concerns the gene CASC15 and gastric cancer.